{"id":{"repo_id":"ohiolink","oai_identifier":"oai:etd.ohiolink.edu:case1365441184"},"canonical_url":"https://search.dev.ndltd.org/etd/ohiolink/oai:etd.ohiolink.edu:case1365441184","repository":{"repo_id":"ohiolink","name":"OhioLINK","base_url":"https://etd.ohiolink.edu/acprod/odb_etd/ws/oai/oai"},"display":{"title":"Business Development and Commercialization of UroSense™.","abstract":"Future Path Medical Holding Company, LLC is a medical device start-up company that has developed a breakthrough product called UroSense™. The device is a sensor-integrated urine drainage bottle that automates urine output and core body temperature (CBT) data in catheterized patients. These two vital signs are currently being measured by manual, time-intensive and inaccurate methods and are important indicators to facilitate early treatment and diagnosis. UroSense™ is an advanced urological system that is also equipped with programmable alarms that trigger when the urine bottle is full thus serving as a warning system to caregivers. Future Path Medical has targeted the hospital intensive care unit (ICU) market as its early adopters focusing on catheterized patients. The company has secured two patents for its device and has received class II 510K approval from the FDA. Future Path Medical is currently in its pre-production stage of the device and intends to launch the product in the market in 2013.","abstract_html":"Future Path Medical Holding Company, LLC is a medical device start-up company that has developed a breakthrough product called UroSense™. The device is a sensor-integrated urine drainage bottle that automates urine output and core body temperature (CBT) data in catheterized patients. These two vital signs are currently being measured by manual, time-intensive and inaccurate methods and are important indicators to facilitate early treatment and diagnosis. UroSense™ is an advanced urological system that is also equipped with programmable alarms that trigger when the urine bottle is full thus serving as a warning system to caregivers. Future Path Medical has targeted the hospital intensive care unit (ICU) market as its early adopters focusing on catheterized patients. The company has secured two patents for its device and has received class II 510K approval from the FDA. Future Path Medical is currently in its pre-production stage of the device and intends to launch the product in the market in 2013.","abstract_has_math":false,"creators":["Pasha, Malaikah"],"institution":"Case Western Reserve University School of Graduate Studies","degree_name":"Master of Sciences","degree_level":"masters","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Ritzmann, Roy"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-08-19","date_published":"2013-08-19","updated_at":"2026-07-24T03:37:31Z","subjects":["Biology","Business Education"],"languages":["English"],"rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1365441184","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Ritzmann, Roy"]},{"key":"dc:creator","label":"Author","values":["Pasha, Malaikah"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013-08-19"]},{"key":"dc:publisher","label":"Institution","values":["Case Western Reserve University School of Graduate Studies / OhioLINK"]},{"key":"dc:type","label":"Dc Type","values":["Electronic Thesis or Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Sciences"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Case Western Reserve University School of Graduate Studies"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology","Business Education"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://rave.ohiolink.edu/etdc/view?acc_num=case1365441184"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Future Path Medical Holding Company, LLC is a medical device start-up company that has developed a breakthrough product called UroSense™. The device is a sensor-integrated urine drainage bottle that automates urine output and core body temperature (CBT) data in catheterized patients. These two vital signs are currently being measured by manual, time-intensive and inaccurate methods and are important indicators to facilitate early treatment and diagnosis. UroSense™ is an advanced urological system that is also equipped with programmable alarms that trigger when the urine bottle is full thus serving as a warning system to caregivers. Future Path Medical has targeted the hospital intensive care unit (ICU) market as its early adopters focusing on catheterized patients. The company has secured two patents for its device and has received class II 510K approval from the FDA. Future Path Medical is currently in its pre-production stage of the device and intends to launch the product in the market in 2013."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","p.84","1.97 MB"]},{"key":"dc:title","label":"Title","values":["Business Development and Commercialization of UroSense™."]}]}],"canonical_facts":{"dc:contributor":["Ritzmann, Roy"],"dc:creator":["Pasha, Malaikah"],"dc:date":["2013-08-19"],"dc:description":["Future Path Medical Holding Company, LLC is a medical device start-up company that has developed a breakthrough product called UroSense™. The device is a sensor-integrated urine drainage bottle that automates urine output and core body temperature (CBT) data in catheterized patients. These two vital signs are currently being measured by manual, time-intensive and inaccurate methods and are important indicators to facilitate early treatment and diagnosis. UroSense™ is an advanced urological system that is also equipped with programmable alarms that trigger when the urine bottle is full thus serving as a warning system to caregivers. Future Path Medical has targeted the hospital intensive care unit (ICU) market as its early adopters focusing on catheterized patients. The company has secured two patents for its device and has received class II 510K approval from the FDA. Future Path Medical is currently in its pre-production stage of the device and intends to launch the product in the market in 2013."],"dc:format":["application/pdf","p.84","1.97 MB"],"dc:identifier":["http://rave.ohiolink.edu/etdc/view?acc_num=case1365441184"],"dc:language":["English"],"dc:publisher":["Case Western Reserve University School of Graduate Studies / OhioLINK"],"dc:rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"dc:subject":["Biology","Business Education"],"dc:title":["Business Development and Commercialization of UroSense™."],"dc:type":["Electronic Thesis or Dissertation"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Sciences"],"thesis:institution_name":["Case Western Reserve University School of Graduate Studies"]},"updated_at":"2026-07-24T03:37:31Z"}